Beximco Pharmaceuticals (LON:BXP) Stock Crosses Above 50-Day Moving Average – Should You Sell?

Beximco Pharmaceuticals Limited (LON:BXP) crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 41.85 and traded as high as GBX 42.50. Beximco Pharmaceuticals shares last traded at GBX 42, with a volume of 20,000 shares traded.

Beximco Pharmaceuticals Stock Performance

The stock has a 50 day moving average of GBX 41.85 and a 200 day moving average of GBX 42.64. The company has a debt-to-equity ratio of 12.47, a current ratio of 2.13 and a quick ratio of 0.37. The firm has a market cap of £189.60 million, a P/E ratio of 0.03 and a beta of 0.61.

Beximco Pharmaceuticals Company Profile

Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Incorporated in 1976, the Company started its operation by importing products from Bayer, Germany and Upjohn, USA and selling them in the local market. In 1980, Beximco Pharma began manufacturing of these products under licensing arrangement and in 1983 launched its own formulation brands. Since its inception, the Company remains committed to health and wellbeing of people across all the continents by providing access to contemporary medicines.